QA: Sio Gene Therapies Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2020_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 114,584,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,278,000
3 remainder_Assets 6,844,000
4 LiabilitiesCurrent 43,499,000
5 LiabilitiesNoncurrent 22,994,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 49,470,192
9 ResearchAndDevelopmentExpense 38,654,367
10 remainder_Expenses 7,728,681
11 remainder_Revenues 0
12 remainder_NetIncome 32,570,100
13 remainder_ComprehensiveNetIncome -252,000
  yvar yval
0 Assets 122,706,000
1 Liabilities 66,493,000
2 Expenses 95,853,240
3 Revenues 0
4 StockholdersEquity 56,213,000
5 NetIncome -63,283,140
6 ComprehensiveNetIncome -63,409,140
7 BaseVar 158,937,170
8 EconomicCapitalRatiobeforeLimitedLiability 0.625
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time